Piper Jaffray Goes Overweight Sarepta, Expects FDA To Accept Next Key Drug Filing

By: via Benzinga
Shares of Sarepta Therapeutics, Inc. (NASDAQ: SRPT) have risen over 132 percent, year to date, reaching a peak on August 17, of ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.